Global Pleural Diseases Therapeutics Industry Set to Flourish with a Projected 6.5% CAGR, Reaching US$ 9.4 Billion by 2033 | FMI

Future Market Insights (FMI), a leading market intelligence and consulting firm, has released a comprehensive study on the Global Pleural Disease Therapeutics Industry, shedding light on its anticipated growth trajectory from 2023 to 2033. The market is projected to be valued at US$ 4.98 billion in 2023, with a remarkable compounded annual growth rate (CAGR) …